青光眼市场报告：2030 年趋势、预测与竞争分析

青光眼趋势和预测

预计到 2030 年，全球青光眼市场将达到 120.4 亿美元，2024 年至 2030 年复合年增长率为 7.0%。该市场的主要驱动因素是青光眼盛行率的增加、人们对青光眼的认识不断提高以及眼科领域对新型治疗策略的需求不断增长。全球青光眼市场的未来前景广阔，医院药局、零售药局和线上药局市场充满机会。

青光眼市场洞察

Lucintel 预测，由于睡眠呼吸中止症、血管疾病和视力模糊等与老龄化相关的眼科疾病率不断上升，开放性青光眼在预测期内将出现最高增长。

由于诊断、治疗和新药管理方面的进步，预计亚太地区在预测期内将出现最高增长

常问问题

Q.1 青光眼的市场规模有多大？

A1. 到2030年，全球青光眼市场预计将达到120.4亿美元。

Q.2 青光眼市场的成长预测是多少？

A2. 2024年至2030年，全球青光眼市场预计将以7.0%的复合年增长率成长。

Q.3 影响青光眼市场成长的关键因素有哪些：

A3. 该市场的主要驱动力是青光眼盛行率的增加、对青光眼的认识不断提高以及眼科领域对新型治疗策略的需求不断增长。

Q4.市场的主要细分市场是：

A4. 青光眼市场前景广阔，医院药局、零售药局、网路药局市场充满机会。

Q5.市场的主要企业是：

A5.主要的青光眼公司如下。

• Pfizer
• Santen Pharmaceutical
• Novartis
• Alcon
• Akron Operating Company
• Thea Pharma
• AbbVie
• Bausch+Lomb Corporation
• Teva Pharmaceuticals Industries
• 0

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，由于睡眠呼吸中止症、血管疾病和视力模糊等与老龄化相关的眼科疾病盛行率不断上升，开放性青光眼将在预测期内出现最高增长。Masu。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于诊断、治疗和新药交付方面的进步，预计亚太地区将在预测期内实现最高增长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球青光眼市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球青光眼市场趋势（2018-2023）与预测（2024-2030）
• 按疾病类型分類的全球青光眼市场
  • 开放性青光眼
  • 隅角闭锁性青光眼
  • 其他的
• 按药物类别分類的全球青光眼市场
  • Gland类似物
  • β受体阻断剂
  • 肾上腺素能促效剂
  • 碳酸酐酶抑制剂
  • 其他的
• 按分销通路分類的全球青光眼市场
  • 医院药房
  • 零售药房
  • 网路药房

第四章 2018-2030年区域市场趋势及预测分析

• 全球青光眼市场按地区划分
• 北美青光眼市场
• 欧洲青光眼市场
• 亚太青光眼市场
• 其他地区青光眼市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 按疾病类型分類的全球青光眼市场成长机会
  • 按药物类别分類的全球青光眼市场成长机会
  • 按分销管道分類的全球青光眼市场成长机会
  • 按地区分類的全球青光眼市场成长机会
• 全球青光眼市场新趋势
• 战略分析
  • 新产品开发
  • 扩大全球青光眼市场的产能
  • 全球青光眼市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业概况

• Pfizer
• Santen Pharmaceutical
• Novartis
• Alcon
• Akron Operating Company
• Thea Pharma
• AbbVie
• Bausch+Lomb Corporation
• Teva Pharmaceuticals Industries

Glaucoma Trends and Forecast

The future of the global glaucoma market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global glaucoma market is expected to reach an estimated $12.04 billion by 2030 with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are increasing glaucoma incidence rates and increasing glaucoma awareness and growing need in the field of ophthalmology for novel treatment strategies.

A more than 150-page report is developed to help in your business decisions.

Glaucoma by Segment

The study includes a forecast for the global glaucoma by disease type, drug class, distribution channel, and region.

Glaucoma Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

• Open Angle Glaucoma
• Angle Closure Glaucoma
• Others

Glaucoma Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

• Prostaglandins Analogs
• Beta-blockers
• Adrenergic Agonists
• Carbonic Anhydrase Inhibitors
• Others

Glaucoma Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Glaucoma Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Glaucoma Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies glaucoma companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the glaucoma companies profiled in this report include-

• Pfizer
• Santen Pharmaceutical
• Novartis
• Alcon
• Akron Operating Company
• Thea Pharma
• Abbvie
• Bausch + Lomb Corporation
• Teva Pharmaceuticals Industries

Glaucoma Market Insights

Lucintel forecasts that open angle glaucoma is expected to witness highest growth over the forecast period due to rising prevalence of age-related eye conditions such sleep apnea, vascular diseases, and blurred vision.

Asia Pacific is expected to witness highest growth over the forecast period due to advancements in the diagnosis, treatment, and administration of new medications

Features of the Global Glaucoma Market

Market Size Estimates: Glaucoma market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Glaucoma market size by disease type, drug class, distribution channel, and region in terms of value ($B).

Regional Analysis: Glaucoma market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different disease type , drug class , distribution channel , and regions for the glaucoma market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the glaucoma market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the glaucoma market size?

Answer: The global glaucoma market is expected to reach an estimated $12.04 billion by 2030.

Q.2 What is the growth forecast for glaucoma market?

Answer: The global glaucoma market is expected to grow with a CAGR of 7.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the glaucoma market?

Answer: The major drivers for this market are increasing glaucoma incidence rates and increasing glaucoma awareness and growing need in the field of ophthalmology for novel treatment strategies.

Q4. What are the major segments for glaucoma market?

Answer: The future of the glaucoma market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.

Q5. Who are the key glaucoma market companies?

Answer: Some of the key glaucoma companies are as follows.

• Pfizer
• Santen Pharmaceutical
• Novartis
• Alcon
• Akron Operating Company
• Thea Pharma
• AbbVie
• Bausch + Lomb Corporation
• Teva Pharmaceuticals Industries
• 0

Q6. Which glaucoma market segment will be the largest in future?

Answer: Lucintel forecasts that open angle glaucoma is expected to witness highest growth over the forecast period due to rising prevalence of age-related eye conditions such sleep apnea, vascular diseases, and blurred vision.

Q7. In glaucoma market, which region is expected to be the largest in next 5 years?

Answer: Asia Pacific is expected to witness highest growth over the forecast period due to advancements in the diagnosis, treatment, and administration of new medications.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the glaucoma market by disease type (open angle glaucoma, angle closure glaucoma, and others), drug class (prostaglandins analogs, beta-blockers, adrenergic agonists, carbonic anhydrase inhibitors, and others), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Glaucoma Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Glaucoma Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Glaucoma Market by Disease Type
  • 3.3.1: Open Angle Glaucoma
  • 3.3.2: Angle Closure Glaucoma
  • 3.3.3: Others
• 3.4: Global Glaucoma Market by Drug Class
  • 3.4.1: Prostaglandins Analogs
  • 3.4.2: Beta-blockers
  • 3.4.3: Adrenergic Agonists
  • 3.4.4: Carbonic Anhydrase Inhibitors
  • 3.4.5: Others
• 3.5: Global Glaucoma Market by Distribution Channel
  • 3.5.1: Hospital Pharmacy
  • 3.5.2: Retail Pharmacy
  • 3.5.3: Online Pharmacy

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Glaucoma Market by Region
• 4.2: North American Glaucoma Market
  • 4.2.2: North American Glaucoma Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
• 4.3: European Glaucoma Market
  • 4.3.1: European Glaucoma Market by Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, and Others
  • 4.3.2: European Glaucoma Market by Distribution Channe: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
• 4.4: APAC Glaucoma Market
  • 4.4.1: APAC Glaucoma Market by Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, and Others
  • 4.4.2: APAC Glaucoma Market by Distribution Channe: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
• 4.5: ROW Glaucoma Market
  • 4.5.1: ROW Glaucoma Market by Disease Type : Open Angle Glaucoma, Angle Closure Glaucoma, and Others
  • 4.5.2: ROW Glaucoma Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Glaucoma Market by Disease Type
  • 6.1.2: Growth Opportunities for the Global Glaucoma Market by Drug Class
  • 6.1.3: Growth Opportunities for the Global Glaucoma Market by Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Glaucoma Market by Region
• 6.2: Emerging Trends in the Global Glaucoma Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Glaucoma Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glaucoma Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Pfizer
• 7.2: Santen Pharmaceutical
• 7.3: Novartis
• 7.4: Alcon
• 7.5: Akron Operating Company
• 7.6: Thea Pharma
• 7.7: AbbVie
• 7.8: Bausch + Lomb Corporation
• 7.9: Teva Pharmaceuticals Industries